Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

585
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
585
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

156
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
156
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

97
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
97
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

108
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Genetic Screens02:46

Genetic Screens

5.4K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.4K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

3.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted amplicon sequencing for enhanced detection of spiked Shiga toxin-producing <i>Escherichia coli</i> in ready-to-eat romaine lettuce: a proof-of-concept study.

Microbiology spectrum·2026
Same author

Pathfinder: a modified collaborative game for learning and team development.

Innovations in pharmacy·2026
Same author

Evaluating the compatibility, stability, and antimicrobial effectiveness of vancomycin and cefepime admixtures in peritoneal dialysis solutions.

Scientific reports·2026
Same author

A Comprehensive Bibliometric Analysis of U.S. Neurosurgical Residency Programs: Evaluating Recent Research Productivity, Citation Impact, and Publication Equity.

Cureus·2026
Same author

Psychosocial impact of chronic oral mucosal pain disorders: Associations with oral health related quality of life, anxiety, and depression.

Journal of oral biology and craniofacial research·2026
Same author

Dynamic Reprogramming of PDGFRA-Expressing Stromal Cells Facilitates WNT-Driven Transformation by Promoting a Fetal-Like State in the Intestinal Epithelium.

Cancer research·2026

Related Experiment Video

Updated: Dec 9, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.5K

Clinical Application and Educational Training for Pharmacogenomics.

Jason W Guy1, Isha Patel2, Julie H Oestreich3

  • 1Department of Pharmacy Practice, College of Pharmacy, University of Findlay, Findlay, OH 45840, USA.

Pharmacy (Basel, Switzerland)
|September 9, 2020
PubMed
Summary

Pharmacogenomics, the study of gene-drug interactions, is crucial for personalized medicine. Education is key to integrating genetic testing for optimized medication selection and improved patient outcomes.

Keywords:
clinical outcomespharmacogenomicspharmacogenomics educationpharmacy education

More Related Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.0K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.0K

Related Experiment Videos

Last Updated: Dec 9, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.5K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.0K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.0K

Area of Science:

  • Pharmacogenomics and clinical pharmacology
  • Genetics and personalized medicine

Background:

  • Pharmacogenomics, the study of how genes influence drug response, is increasingly vital in healthcare.
  • Evidence and drug labeling support pharmacogenomic applications in patient care.
  • Genetic testing offers potential for optimizing medication selection and dosing.

Purpose of the Study:

  • To review current evidence supporting the clinical use of medications with pharmacogenomic labeling.
  • To examine educational strategies for health professionals and trainees in pharmacogenomics.
  • To highlight the importance of pharmacogenomics in routine clinical practice.

Main Methods:

  • Literature review of evidence supporting pharmacogenomic applications.
  • Analysis of current educational approaches for healthcare providers.
  • Synthesis of data on the integration of pharmacogenomics into clinical decision-making.

Main Results:

  • Growing body of evidence supports pharmacogenomic applications in clinical settings.
  • Integration of pharmacogenomics into practice remains variable and faces challenges.
  • Educational initiatives are crucial for widespread adoption and consistent application.
  • Genotype-guided dosing shows promise for improving patient outcomes.

Conclusions:

  • Pharmacogenomics is essential for optimizing medication therapy and patient outcomes.
  • Enhanced education for healthcare professionals is critical for successful pharmacogenomic integration.
  • Standardized educational strategies are needed to ensure competent application of pharmacogenomics in healthcare.